Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Mankind has MKP10241, a small-molecule oral obesity drug, in Phase II in Australia
Packer M et al., SUMMIT, NEJM 2024 (NEJMoa2410027, PMID 39555826) : tirzepatide and HFpEF with obesity, HR 0,62 composite endpoint
Mol Biol Rep 2013;40(1):687-695
Chin Opt Lett 7(4):357360 Pang Y, Huang YK, Li F, Yangc FQ, Xia ZN (2016) Rapid screening and evaluation of antioxidants in alkaloid natural products by capillary electrophoresis with chemiluminescence detection
Trust Signals Written by: FormBlends Medical Team, reviewed against primary literature
US$ 23.19
US$ 22.44
US$ 27.76
US$ 20.05
US$ 21.35
US$ 22.14
US$ 23.31
